Platelets Market Size & Share, by Type (Apheresis Derived Platelets, Whole-blood Derived Platelet); Application (Thrombocytopenia, Hemato-oncology, Perioperative Indications, Hemophilia, Platelet, Function Disorders); End user - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 7152
  • Published Date: Feb 17, 2025
  • Report Format: PDF, PPT

Global Platelets Market

  1. An Outline of the Global Platelets Market   
    1. Market Definition
    2. Market Segmentation 
  2.  Assumptions and Abbreviations
  3. Research Methodology & Approach
    1. Primary Research
    2. Secondary Research
    3. Data Triangulation
    4. SPSS Methodology 
  4. Executive Summary
  5. Growth Drivers
  6. Major Roadblocks
  7. Opportunities
  8. Prevalent Trends 
  9. Government Regulation: How they would aid business?
  10. Technological Advancements
  11. Growth Outlook
  12. Risk Overview
  13. SWOT
  14. Regional Demand
  15. Platelets Type Analysis
  16. Growth Potential for End-User of Platelets Market
  17. Exploring Platelet Preparation Method
  18. Overview of Companies Innovating in Artificial Platelet Production
  19.  Root Cause Analysis (RCA) for discovering problems of the Platelets Market
  20. Epidemiological Analysis of Diseases
  21. Key Patients and Use Cases for Platelet Applications
  22. Issues and Area for Improvement in Transfusion-Derived Platelets Products
  23. Factors Leading to Potential Shortage of Platelets Products
  24. Analysis of Past Platelets Shortages and Future Projections During Emergencies
  25. Platelet-Rich Plasma Market Size
  26. Trends in Platelet-Rich Plasma (PRP)
  27. Potential for Artificial Platelets to Replace Current Platelet Products
  28. Promising Technologies in Artificial Platelets
  29. Logistics and Distribution Players for Platelet Products: Detailed Analysis
  30. Comparative Positioning
  31. Competitive Landscape: Key Players
  32. Competitive Model: A Detailed Inside View for Investors 
    1. Aggredyne Inc.
    2. American National Red Cross
    3. Arthrex, Inc
    4. Asahi Kasei Medical Co., Ltd.
    5. Cellphire, Inc.
    6. Eurobio Scientific UK
    7. Terumo Corporation
    8. Thermo Fisher Scientific Inc
    9. Sysmex Corporation
    10. Zimmer Biomet  
  33. Global Platelets Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (Y-o-Y) Growth Trend Analysis
    4. Global Platelets Market Segmentation Analysis (2024-2037)
      1. By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Geography
        1. North America , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Europe , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Asia Pacific excluding Japan , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Japan , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Latin America , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        6. Middle East and Africa , Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
    5. Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  34. North America Platelets Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (Y-o-Y) Growth Trend Analysis
    4. North America Platelets Market Segmentation Analysis (2024-2037)
      1.  By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Country
        1. U.S., Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Canada, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    5. Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
    6.  
  35. Europe Platelets Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (Y-o-Y) Growth Trend Analysis
    4. Europe Platelets Market Segmentation Analysis (2024-2037)
      1. By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Country
        1.  UK, , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Germany, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. France , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Italy , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Spain , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        6. BENELUX , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        7. Poland , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        8. Russia , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        9. Rest of Europe , Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    5. Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  36. Asia Pacific Excluding Japan Platelets Market Outlook
    1. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    2. Year-on-Year (Y-o-Y) Growth Trend Analysis
    3. Asia Pacific excluding Japan Platelets Market Segmentation Analysis (2024-2037)
    4. Platelets Market Segmentation Analysis (2024-2037)
      1. By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4.  By Country
        1. China, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. India, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Indonesia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. South Korea, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Malaysia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        6. Australia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        7. Singapore, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        8. Vietnam, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        9. New Zealand, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        10. Rest of APEJ, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    5.  Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  37. Japan Platelets Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (Y-o-Y) Growth Trend Analysis
    4. Japan Platelets Market Segmentation Analysis (2024-2037)
      1.  By Type
      2. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Application
      5. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      8. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      9. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      10. By End user
      11. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      12. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      13. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    5.  Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  38. Latin America Platelets Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Year-on-Year (Y-o-Y) Growth Trend Analysis
    4. Latin America Platelets Market Segmentation Analysis (2024-2037)
      1. By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4.  By Country
        1.  Brazil, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Argentina, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Mexico, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Rest of Latin America, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    5. Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  39. Middle East & Africa Platelets Market Outlook 
    1. Market Overview
    2. Market Revenue by Value (USD Million), and Compound Annual Growth Rate (CAGR)
    3. Platelets Market Segmentation Analysis (2024-2037)
      1. By Type
        1. Apheresis derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Whole-blood derived platelets, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Application
        1. Thrombocytopenia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Hemato-oncology, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Hemophilia, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Platelet, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        5. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037FBy Facility
      3. By End user
        1. Hospitals, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Ambulatory surgical centers, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Country
        1.  GCC, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Israel, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. South Africa, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Rest of Middle East & Africa, Value (USD Million), CAGR & Y-o-Y Growth Trend, 2024-2037F
    4. Cross Analysis of Type W.R.T. End-User (USD Million), 2024-2037
  40. Global Economic Scenario
  41. About Research Nester

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Platelets Market size was valued at USD 5.5 billion in 2024 and is projected to reach a valuation of USD 11.1 billion by the end of 2037, rising at a CAGR of 5.3% during the forecast period, i.e., 2025-2037. In 2025, the industry size of platelets is assessed at USD 5.9 billion.

The growth of the platelets market is driven by an increase in the number of blood disorders, cancer treatment, and trauma cases that require platelet transfusions. With the increase in global cancer rates, including chemotherapy-induced thrombocytopenia, the necessity of advanced platelet storage, collection, and manufacturing techniques has increased. In June 2024, Satake MultiMix, Kyoto University, and the University of Miyazaki produced clinical-grade platelets at a 45-liter scale, a major step in producing platelets at a large scale for transfusion medicine. Such advancements are making platelet supply chains more reliable and improving patient care.

Platelet shortages are also addressed by government initiatives. In 2024, the World Health Organization (WHO) reported that 118.5 million blood donations are made yearly around the world and that 40% of these come from high-income countries. To guarantee an adequate supply, governments are investing in blood banks, platelet storage innovations, and voluntary donor programs. In June 2024, the Pan American Health Organization (PAHO) stressed the need for voluntary blood donations to ensure a stable supply of platelets to hospitals, especially in rural areas. This highlights the rising requirement for efficient collection, storage, and transfusion systems.


Platelets Market Size
Get more information on this report: Request Free Sample PDF

Platelets Market: Growth Drivers and Challenges

Growth Drivers

  • Rising incidence of hematologic diseases, hemophilia, and thrombocytopenia: Hematologic diseases, hemophilia, and thrombocytopenia are anticipated to be on the rise in the near future, thereby increasing the demand for platelet transfusion. WHO estimates in 2022 reported more than 1 million new cancer cases in Japan, where chemotherapy-induced thrombocytopenia is of major concern. In order to overcome this problem, both freeze-dried platelet-derived hemostats (FPH) and cryopreserved platelets are being developed with the aim of improving supply stability. In May 2024, Vitalant and Cellphire Therapeutics joined forces to improve platelet storage solutions so that platelet transfusions are readily available to oncology and trauma patients. The number of cancer treatments that need platelet support is growing, and the demand for sustainable platelet sources continues to increase.
  • Demand for platelet storage and cryopreservation: Innovations in platelet storage and cryopreservation are also contributing to extending the shelf life of platelets and contributing to reducing transfusion related shortages. Traditional platelets have a short shelf life of 5–7 days, so inventory management is difficult. Helmer Scientific introduced the Pro Line Floor Model Platelet Storage System in August 2023, delivering OptiCool RT Technology for accurate temperature control and platelet agitation. These advanced storage systems assist in maintaining platelet viability and thereby ensuring effective transfusion in patients with critical blood disorders. With a growing global platelet demand, it is essential to optimize storage solutions to minimize wastage and improve accessibility.
  • Blood transfusion infrastructure government support: To counter supply chain disruptions and provide steady platelet availability, governments are allocating funds to blood banks and sophisticated platelet collection technologies. The American Red Cross said in September 2024 that it needs enough platelets to provide care for the patients of oncology, trauma, and emergency medicine. Meanwhile, the United Nations anticipates that by 2050, more than 2.1 billion people will be aged 60 or older, making platelet transfusion more necessary for treating cardiovascular diseases and thrombocytopenia. Modernization of blood transfusion networks and improvement of platelet collection efficiency worldwide will be made possible by these government-backed initiatives.

Challenges

  • Short shelf life and supply chain constraints: Platelets have a short shelf life of only 5–7 days, increasing the risk of shortages in places with high demand. As such, it requires continuous replenishment from donors and efficient storage systems to keep up adequate supplies. The availability of platelets in emergencies is often limited in hospitals, therefore, innovative solutions for storage and supply chain management are required to provide timely access to patients in critical need.
  • Risk of contamination and disease transmission: Platelets are stored at room temperature, which makes them more vulnerable to bacterial contamination. This presents a risk of infection to transfusion recipients, and therefore, strict quality control and advanced sterilization techniques are essential. It is important to guarantee the safety and sterility of platelet products to avoid complications and preserve the health of patients who get transfusions.

Base Year

2024

Forecast Year

2025-2037

CAGR

5.3%

Base Year Market Size (2024)

USD 5.5 billion

Forecast Year Market Size (2037)

USD 11.1 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Platelets Segmentation

Type (Apheresis Derived Platelets, Whole-blood Derived Platelet)

Apheresis derived platelets segment is projected to dominate platelets market share of around 54% by the end of 2037, owing to its ability to collect higher quality platelets with reduced donor exposure. Apheresis platelets are collected from one donor, unlike traditional whole blood platelets, and therefore have reduced risk of infection and immune reaction. In June 2024, Kyoto University produced a large-scale platelet bioreactor for large-scale platelet production in transfusion medicine to meet the growing demand for apheresis platelets. Apheresis derived platelets are expected to continue being the dominant segment in the market due to the growing platelet demand in oncology and trauma care.

Application (Thrombocytopenia, Hemato-oncology, Perioperative Indications, Hemophilia, Platelet, Function Disorders)   

In platelets market, thrombocytopenia segment is expected to dominate revenue share of around 28.4% by the end of 2037, due to the increasing number of chemotherapies that lead to platelet deficiency. Patients receiving cancer treatment often have low platelet counts that necessitate frequent transfusions to avoid serious bleeding complications. In May 2023, Regen Lab is CE certified for PRP therapies that can improve thrombocytopenia treatment with regenerative medicine. Demand for platelet-based treatments is increasing due to the increasing global aging population and the rising prevalence of cancer.

Our in-depth analysis of the global platelets market includes the following segments:

Type

  • Apheresis Derived Platelets
  • Whole-blood Derived Platelet

Application 

  • Thrombocytopenia 
  • Hemato-oncology 
  • Perioperative Indications 
  • Hemophilia 
  • Platelet Function Disorders 

End user

  • Hospitals 
  • Ambulatory Surgical Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Platelets Industry - Regional Synopsis

North America Market Analysis

North America platelets market is set to account for revenue share of more than 32% by the end of 2037, Increasing platelet transfusions in oncology, trauma care, and surgical procedures drive the region's market growth. Furthermore, the demand for platelet rich plasma (PRP) and transfusions is constantly expanding with an aging population and rising chronic diseases. However, the supply chain is constrained by stringent FDA regulations and dependence on voluntary blood donations, so there is a need for improved platelet storage and preservation. Shortages of platelets and the need to make them more accessible to patients have led the industry to move toward the use of bioreactors and cryopreserved platelets.

The U.S. is anticipated to witness considerable expansion during the forecast period. Trauma and cancer patients in the U.S. require approximately 5,000 units of platelets daily, creating a constant demand for blood and platelet donations. The country relies on platelet donations, as nearly 16 million blood components are transfused annually. Policies of reimbursement and technological advances, including freeze-dried platelet solutions, are facilitating access to platelet therapy. Nevertheless, the short shelf life and the high risk of bacterial contamination are still major obstacles. AI powered blood banking systems and automated platelet storage solutions are being explored by industry to improve efficiency and reliability in the process.

As healthcare needs grow, Canada is working to expand its platelet supply and PRP therapy applications. Canadian Blood Services reports that more than 100,000 platelet units are collected each year to support hematology, organ transplants, and surgical procedures. To avoid supply shortages and dependence on donations, synthetic platelets are being studied by research institutions. In November 2023, a team of researchers at McMaster University announced that they invented nanoparticle-based platelet substitutes for trauma and emergency medicine. Innovations such as these are expected to bolster the country’s position in platelet-related healthcare breakthroughs.

Asia Pacific excluding Japan Platelets Market Statistics

Asia Pacific excluding Japan platelets market is set to witness growth rate of over 6% till 2037. Growth in the market is driven by increasing medical tourism, increasing number of cases of chronic illnesses, and higher awareness of platelet-based regenerative medicine. Advanced blood banking infrastructure is being invested by the government, improving platelet storage and transfusion efficiency. Additionally, it is the region of innovation for biotechnology applications of platelet-rich plasma (PRP) technologies, resulting in increased demand for platelet derived treatments in orthopedics, dermatology, and hair restoration.

India is becoming a significant platelets market for platelet-based therapies, and PRP applications in dermatology and regenerative medicine are gaining traction. In December 2023, Bangalore-based Hairline International Hair and Skin Clinic launched Sonicated PRP, an advanced hair regeneration therapy. Platelet-rich plasma (PRP) technology is used in this technique to stimulate the dormant hair follicles, thus providing more effective hair restoration solutions. India’s platelets market is expanding with the rising adoption of PRP in aesthetic and orthopedic treatments.

China is one of the major players in platelet research and regenerative medicine, with a keen interest in biotechnological advances. AI blood banking and cryopreserved platelet storage solutions are being invested in by the China government to guarantee a steady supply for medical procedures. In November 2023, scientists from Peking University created lab-grown platelet substitutes and showed that they can be used to treat clotting diseases and reduce reliance on donor platelets. China has a rapidly aging population, as a result, cardiovascular diseases are increasing. Due to this rise, the country is accelerating innovations in platelet-based therapies and transfusion medicine.

Platelets Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Platelets Market

    The platelets market is highly competitive, with the leading companies investing in bioreactors, cryopreserved platelet technologies, and platelet-rich plasma (PRP) therapies. Terumo Corporation, Cellphire Therapeutics, Thermo Fisher Scientific, Sysmex Corporation, and Zimmer Biomet are the key players in the platelets market. These firms are also focusing on automated platelet storage, regenerative medicine applications, and global blood transfusion advancements. In August 2024, OrthoGrid Systems, Inc. was acquired by Zimmer Biomet to incorporate AI surgical guidance systems into platelet-based orthopedic treatments. This development illustrates the growing part of AI and precision medicine in platelet therapies and the continued advancements in transfusion medicine and regenerative health solutions.

    Here are some leading companies in the platelets market:

    • Aggredyne Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • American National Red Cross 
    • Arthrex, Inc 
    • Asahi Kasei Medical Co., Ltd. 
    • Cellphire, Inc. 
    • Eurobio Scientific UK 
    • Terumo Corporation 
    • Thermo Fisher Scientific Inc 
    • Sysmex Corporation 
    • Zimmer Biomet

In the News

  • In December 2024, Arthrex announced the development of the Arthrex Observation Suite, designed to enhance surgical education by allowing medical professionals to observe live procedures. The suite will feature advanced OR imaging and technology demonstrations, including potential applications for platelet-rich plasma (PRP) in surgical recovery.
  • In July 2024, Crown Laboratories, through its subsidiary Crown Aesthetics, acquired select assets and technology from Healeon LLC, strengthening its presence in the platelet-rich plasma (PRP) skincare and aesthetics market. The acquisition expands Crown’s portfolio of regenerative treatments utilizing platelet-derived growth factors.
  • In April 2024, Sysmex Europe SE launched Sysmex Nordic ApS in Finland to strengthen its market position in diagnostic solutions. The expansion will enhance Sysmex’s sales and support for advanced hematology and platelet function analysis tools.

Author Credits:   Radhika Pawar


  • Report ID: 7152
  • Published Date: Feb 17, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of platelets was USD 5.5 billion.

The global platelets market size was USD 5.5 billion in 2024 and is expected to reach USD 11.1 billion by the end of 2037, expanding at a CAGR of 5.3% during the forecast period, i.e., 2025-2037. In 2025, the industry size of platelets will be valued at USD 5.9 billion.

Key players in the market are Aggredyne Inc., American National Red Cross, Arthrex, Inc., Asahi Kasei Medical Co., Ltd., Cellphire, Inc., Eurobio Scientific UK, Terumo Corporation, Thermo Fisher Scientific Inc., Sysmex Corporation, Zimmer Biomet.

The thrombocytopenia segment is anticipated to lead the platelets market during the forecast period.

North America is likely to offer significant prospects to the companies in the platelets market during the forecast period.
logo
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

See our insights in action - schedule your demo now!

Live Sample Reading